Peer-reviewed research Insights > Peer-reviewed research A vision of giving back It is fundamental for Signum that insights generated in our research and projects become part of the open, shared body of knowledge on which the pharmaceutical and healthcare sectors advance. On this page you find examples of such projects. Collaboration Our research-based projects are often carried out in collaboration with authorities, universities and other research organizations. This broadens our understanding of the societal context of pharmaceuticals and sharpens our knowledge of new scientific methodologies and technologies. All in all, through our private-public collaboration Signum helps create those synergies that result in better care for patients. Authorised Access to the “Forskermaskine” Signum is authorized by Statistics Denmark and the Danish Health Data Authority to access data on the “Forskermaskine”. This means that our research activities, knowledge of data security and registry data have been officially approved. Consequently, we are able to gain access to microdata for the projects we solve. Medical adherence to glaucoma treatment In collaboration with AbbVie, we conducted a study based on Danish real-world data to investigate the predictors of adherence to glaucoma treatment, long-term adherence patterns, and long-term economic consequences of poor adherence. Read more Long-term insulin treatment of Type 1 and 2 diabetics Analyzing statistical data from the Danish Health Data Authority to map T1D and T2D treatment with basal insulin: The types of drugs prescribed for new patients, and the number of changes in drugs. Contact us for more information Nordic research collaboration – IBD study Signum participated in a Nordic collaboration coordinated by Oslo University to map the treatment of patients suffering from inflammatory bowel disease with biological drugs. Contact us for more information Modelling Cost Efficiency of Biological Treatment Signum participated as supervisors for a thesis (University of Copenhagen, Department of Public Health) to model cost-effectiveness of biological treatment of inflammatory bowel diseases. Contact us for more information Chronic Obstructive Pulmonary Disease Analysis On behalf of GSK, we conducted a real-world data analysis of COPD on different aspects of treatment and the patient journey in Denmark. The most frequent treatment was found to be triple therapy. Contact us for more information Real-World Data Study of ADHD-patients in Denmark On behalf of Medice Nordic Denmark ApS, Signum conducted a real-world data (RWD) analysis of the trends in the medical treatment for ADHD. Read the case RWE Analysis of cost of medicine for adults with ADHD Signum conducted a real-world data analysis of adults in stable treatment with ADHD medicine in order to explore the characteristics and cost of medicine for adults with ADHD. Contact us for more information Get in touch Leave a message and we will get back to you ASAP. We process your personal information in accordance with our Privacy Policy. First Name: Last Name: Company: E-mail: Your Message:
